Filing Flows › Treace Medical Concepts (TMCI) › Q2 2026 › vs Q2 2025
Treace Medical Concepts (TMCI) Q2 2026 vs Q2 2025 (year over year)
Treace Medical Concepts's revenue fell $2.0M (-4%) from $47.4M in Q2 2025 to $45.4M in Q2 2026.
Treace Medical Concepts, Q2 2026: revenue $45.4M (-4% year over year), operating margin -33.0%, net loss $15.9M, operating cash flow −$4.7M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $45.4M | $47.4M | −$2.0M | -4% |
| Net loss | $15.9M | $17.4M | −$1.5M | -9% |
| Costs & expenses | $61.2M | $64.8M | −$3.5M | -5% |
| Operating costs | $60.3M | $64.4M | −$4.0M | -6% |
| Interest & other, net | $915K | $424K | $491K | +116% |
| Cost of revenue | $9.8M | $9.6M | $134K | +1% |
| Research & development | $4.4M | $5.5M | −$1.1M | -20% |
| Sales & marketing | $30.9M | $33.1M | −$2.1M | -6% |
| General & admin | $15.2M | $16.1M | −$895K | -6% |
| Operating cash sources | $15.9M | $17.4M | −$1.5M | -9% |
| Depreciation & amortization | $1.9M | $2.6M | −$688K | -27% |
| Share-based compensation | $6.5M | $9.6M | −$3.1M | -33% |
| Working capital & other | $2.8M | $2.2M | $629K | +29% |
| Cash used in operations | $4.7M | $3.0M | $1.6M | +54% |
| Net loss absorbed | $15.9M | $17.4M | −$1.5M | -9% |
Questions
How much did Treace Medical Concepts's revenue grow year over year in Q2 2026?
Treace Medical Concepts's revenue fell $2.0M (-4%) from $47.4M in Q2 2025 to $45.4M in Q2 2026.